{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:07:31Z","timestamp":1792670851843,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.vph.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T02:00:25Z","timestamp":1402279225000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Functional role of protease activated receptors in vascular biology"],"prefix":"10.1016","volume":"62","author":[{"given":"Maria Adele","family":"Alberelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-2819","authenticated-orcid":false,"given":"Erica","family":"De Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2014.06.001_bb0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vph.2014.06.001_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vph.2014.01.005","article-title":"Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner","volume":"62","author":"Gonzales","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.vph.2014.06.001_bb0020","doi-asserted-by":"crossref","first-page":"16977","DOI":"10.1016\/S0021-9258(19)47326-2","article-title":"The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity","volume":"266","author":"Liu","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0025","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.06.001_bb0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm943","article-title":"G13 is an essential mediator of platelet activation in hemostasis and thrombosis","volume":"9","author":"Moers","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vph.2014.06.001_bb0035","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1091\/mbc.9.9.2639","article-title":"Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function","volume":"9","author":"Vouret-Craviari","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.vph.2014.06.001_bb0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/350516a0","article-title":"Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins","volume":"350","author":"Taylor","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vph.2014.06.001_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.37.1.167","article-title":"G protein beta gamma subunits","volume":"37","author":"Clapham","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.vph.2014.06.001_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0955-0674(99)80029-5","article-title":"Signalling through phosphoinositide 3-kinases: the lipids take centre stage","volume":"11","author":"Leevers","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/381516a0","article-title":"Role of the thrombin receptor in development and evidence for a second receptor","volume":"381","author":"Connolly","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.vph.2014.06.001_bb0060","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1073\/pnas.91.20.9208","article-title":"Molecular cloning of a potential proteinase activated receptor","volume":"91","author":"Nystedt","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vph.2014.06.001_bb0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/386502a0","article-title":"Protease-activated receptor 3 is a second thrombin receptor in humans","volume":"386","author":"Ishihara","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.vph.2014.06.001_bb0070","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vph.2014.06.001_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/096805103225002584","article-title":"Activated protein C signals through the thrombin receptor PAR1 in endothelial cells","volume":"9","author":"Riewald","year":"2003","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0080","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/bi9824792","article-title":"Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy","volume":"38","author":"Kuliopulos","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.vph.2014.06.001_bb0085","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1074\/jbc.270.19.11168","article-title":"Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G","volume":"270","author":"Molino","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"issue":"Pt 1","key":"10.1016\/j.vph.2014.06.001_bb0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/bj3200335","article-title":"Cleavage of the thrombin receptor: identification of potential activators and inactivators","volume":"320","author":"Parry","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.vph.2014.06.001_bb0100","doi-asserted-by":"crossref","first-page":"16081","DOI":"10.1074\/jbc.M108555200","article-title":"Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells","volume":"277","author":"Camerer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0105","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1074\/jbc.272.7.4043","article-title":"Interactions of mast cell tryptase with thrombin receptors and PAR-2","volume":"272","author":"Molino","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0110","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.97.10.5255","article-title":"Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa","volume":"97","author":"Camerer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vph.2014.06.001_bb0115","doi-asserted-by":"crossref","first-page":"26333","DOI":"10.1074\/jbc.M002941200","article-title":"Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates","volume":"275","author":"Takeuchi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/BJ20041066","article-title":"The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells","volume":"388","author":"Wilson","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.vph.2014.06.001_bb0125","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.M401431200","article-title":"Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4","volume":"279","author":"Quinton","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0130","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1074\/jbc.275.10.6819","article-title":"Cathepsin G activates protease-activated receptor-4 in human platelets","volume":"275","author":"Sambrano","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1476-5381.2010.00705.x","article-title":"Signal transduction by protease-activated receptors","volume":"160","author":"Soh","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0140","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/blood.V99.10.3629","article-title":"Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling","volume":"99","author":"Kim","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vph.2014.06.001_bb0145","doi-asserted-by":"crossref","first-page":"25299","DOI":"10.1074\/jbc.M313199200","article-title":"Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin","volume":"279","author":"Lova","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2004.07.032","article-title":"Proteinase-activated receptors (PARs)\u2014the PAR3 neo-N-terminal peptide TFRGAP interacts with PAR1","volume":"125","author":"Kaufmann","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.vph.2014.06.001_bb0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pharmthera.2012.01.007","article-title":"Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease","volume":"134","author":"Lee","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vph.2014.06.001_bb0160","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2003-04-1130","article-title":"Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells","volume":"102","author":"Kataoka","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.vph.2014.06.001_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI116206","article-title":"Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor","volume":"91","author":"McNamara","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vph.2014.06.001_bb0170","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1006\/bbrc.1997.7847","article-title":"Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2)","volume":"241","author":"Bono","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vph.2014.06.001_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin-receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2014.06.001_bb0180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2014.06.001_bb0185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.thromres.2011.11.001","article-title":"Mechanisms of platelet activation by thrombin: a short history","volume":"129","author":"De Candia","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jcp.1041560313","article-title":"Thrombin receptor activating peptides induce Ca2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor mRNA expression in cultured endothelium","volume":"156","author":"Garcia","year":"1993","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.vph.2014.06.001_bb0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2007-1002425","article-title":"Thrombin-mediated increase in vascular endothelial permeability","volume":"18","author":"Malik","year":"1992","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.vph.2014.06.001_bb0200","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/01.CIR.95.7.1870","article-title":"Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure","volume":"95","author":"Yang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.06.001_bb0205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1124\/jpet.110.175182","article-title":"Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor alpha and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells","volume":"336","author":"Chieng-Yane","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.vph.2014.06.001_bb0210","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.thromres.2008.04.019","article-title":"Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways","volume":"123","author":"Ivey","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0215","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/01.ATV.0000258793.51013.34","article-title":"Cholesterol enhances thrombin-induced release of fibroblast growth factor-2 in human vascular smooth muscle cells","volume":"27","author":"Rauch","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0022-3565(25)33169-1","article-title":"Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery","volume":"222","author":"De Mey","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.vph.2014.06.001_bb0225","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2008.01.037","article-title":"Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature","volume":"51","author":"Cleator","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/CIRCULATIONAHA.106.638478","article-title":"Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans","volume":"114","author":"Gudmundsdottir","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.06.001_bb0235","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.jacc.2007.12.047","article-title":"Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans","volume":"51","author":"Gudmundsdottir","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.06.001_bb0240","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1161\/01.ATV.19.12.3014","article-title":"Altered vascular injury responses in mice deficient in protease-activated receptor-1","volume":"19","author":"Cheung","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0245","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2004-07-2698","article-title":"Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP","volume":"107","author":"Cleator","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vph.2014.06.001_bb0250","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(93)80055-J","article-title":"Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice","volume":"74","author":"Mayadas","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.vph.2014.06.001_bb0255","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vph.2014.06.001_bb0260","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1126\/science.1061259","article-title":"A role for thrombin receptor signaling in endothelial cells during embryonic development","volume":"293","author":"Griffin","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.vph.2014.06.001_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.ATV.0000251995.73307.2d","article-title":"The roles of proteinase-activated receptors in the vascular physiology and pathophysiology","volume":"27","author":"Hirano","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0270","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.162.9.5466","article-title":"Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion","volume":"162","author":"Rahman","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vph.2014.06.001_bb0275","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.191.3.455","article-title":"Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis","volume":"191","author":"Cunningham","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vph.2014.06.001_bb0280","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI200421689","article-title":"A role for proteinase-activated receptor-1 in inflammatory bowel diseases","volume":"114","author":"Vergnolle","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vph.2014.06.001_bb0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00005344-199711000-00016","article-title":"Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro","volume":"30","author":"Ku","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI116031","article-title":"Thrombin receptor expression in normal and atherosclerotic human arteries","volume":"90","author":"Nelken","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vph.2014.06.001_bb0295","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.RES.80.6.838","article-title":"Vascular thrombin receptor regulation in hypertensive rats","volume":"80","author":"Capers","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0300","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.RES.75.6.1029","article-title":"Characterization of thrombin receptor expression during vascular lesion formation","volume":"75","author":"Wilcox","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0305","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/ATVBAHA.107.159483","article-title":"Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells","volume":"28","author":"Pape","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0310","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0026-895X(25)08703-6","article-title":"Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides","volume":"49","author":"Hollenberg","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0315","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bjp.0702157","article-title":"Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries","volume":"125","author":"Moffatt","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0320","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.bjp.0704714","article-title":"Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries","volume":"136","author":"Hamilton","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0325","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000159233","article-title":"Vascular effects of proteinase-activated receptor 2 agonist peptide","volume":"34","author":"Emilsson","year":"1997","journal-title":"J Vasc Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1139\/y97-176","article-title":"Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo","volume":"76","author":"Cheung","year":"1998","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/hh1301.092661","article-title":"Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists","volume":"89","author":"Hamilton","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0340","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1161\/01.CIR.99.19.2590","article-title":"Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo","volume":"99","author":"Cicala","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.06.001_bb0345","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1139\/cjpp-2012-0266","article-title":"Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice","volume":"91","author":"Hughes","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0350","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000313877","article-title":"Upregulation of proteinase-activated receptor-2 and increased response to trypsin in endothelial cells after exposure to oxidative stress in rat aortas","volume":"47","author":"Aman","year":"2010","journal-title":"J Vasc Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI16913","article-title":"Essential role for proteinase-activated receptor-2 in arthritis","volume":"111","author":"Ferrell","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vph.2014.06.001_bb0360","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1254\/jjp.88.77","article-title":"Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear","volume":"88","author":"Kawagoe","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.vph.2014.06.001_bb0365","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/ATVBAHA.110.219105","article-title":"High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells","volume":"31","author":"Dangwal","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0370","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vph.2014.06.001_bb0375","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1074\/jbc.M110.201228","article-title":"The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors","volume":"286","author":"Disse","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.06.001_bb0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00281-011-0289-1","article-title":"Protease-activated receptor 2 signaling in inflammation","volume":"34","author":"Rothmeier","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vph.2014.06.001_bb0385","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1182\/blood-2005-08-3130","article-title":"Roles of protease-activated receptors in a mouse model of endotoxemia","volume":"107","author":"Camerer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vph.2014.06.001_bb0390","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vph.2014.06.001_bb0395","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.vph.2014.06.001_bb0400","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vph.2014.06.001_bb0405","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2014.06.001_bb0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/SHK.0b013e3181e7e97b","article-title":"Prowess-shock trial: a protocol overview and perspectives","volume":"34","author":"Silva","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.vph.2014.06.001_bb0415","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.thromres.2011.11.013","article-title":"The protein C pathway and sepsis","volume":"129","author":"Della Valle","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.vph.2014.06.001_bb0420","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1160\/TH08-10-0632","article-title":"Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1","volume":"101","author":"Schuepbach","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2014.06.001_bb0425","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/01.CIR.97.6.581","article-title":"Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries","volume":"97","author":"Gallo","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.06.001_bb0430","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/eurheartj\/ehq320","article-title":"Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease","volume":"31","author":"Goto","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.vph.2014.06.001_bb0435","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/CIRCULATIONAHA.110.001404","article-title":"Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin-Coronary Artery Disease Trial","volume":"123","author":"Wiviott","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.06.001_bb0440","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1161\/01.CIR.99.25.3308","article-title":"Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin","volume":"99","author":"De Candia","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.06.001_bb0445","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/pro.5560010402","article-title":"The refined 1.9-A X-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure\u2013function relationships","volume":"1","author":"Bode","year":"1992","journal-title":"Protein Sci"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:29:52Z","timestamp":1746246592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189114001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1537189114001062"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2014.06.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional role of protease activated receptors in vascular biology","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.01.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}